with 5 x 10-10 M CSF-1 . 125 1-CSF-1 binding was exhibited by 4 .3% of bone marrow cells, 7 .5% of blood mononuclear cells, 2 .4% of spleen cells, 20 .5% of peritoneal cells, 11 .8% of pulmonary alveolar cells and 0 .4% of lymph node cells. Four morphologically distinguishable cell types bound 125 1-CSF-1 : blast cells; mononuclear cells with a ratio of nuclear to cytoplasmic area (N/ C) >1 ; cells with indented nuclei ; and mononuclear cells with N/C <_1 . No CSF-1 binding cells were detected among blood granulocytes or thymus cells. Bone marrow promyelocytes, myelocytes, neutrophilic granulocytes, eosinophilic granulocytes, nucleated erythroid cells, enucleated erythrocytes, and megakaryocytes also failed to bind . The frequency distribution of grain counts per cell for blood mononuclear cells was homogenous . In contrast, those for bone marrow, spleen, alveolar, and peritoneal cells were heterogeneous . The monocytes in blood or bone marrow (small cells, with either indented nuclei or with N/C >1) were relatively uniformly labeled, possessing 3,000 binding sites per cell . Larger binding cells (e .g ., alveolar cells) may possess higher numbers of receptors. It is concluded that CSF-1 binding is restricted to mononuclear phagocytic cells and their precursors and that it can be used to identify both mature and immature cells of this series .
ings indicate that the high affinity CSF-1 binding site described in these studies is the receptor through which the biological effects of CSF-1 are mediated (8, 21) .
In this study we examine the distribution, frequency, and morphology of CSF-1 receptor-bearing cells in adult mouse tissues. Binding conditions were chosen to ensure saturation of the cell-surface receptors by 1251-CSF-1 and radioautography was used to identify the binding cells and to determine the number of CSF-1 receptors per cell. We report the existence of a CSF-1 receptor, with common properties, on cells in a variety of tissues and indicate its usefulness as a marker of both mature and immature cells of the mononuclear phagocytic series .
MATERIALS AND METHODS
Preparation of 125 1-CSF-1 L-cell CSF-I was purified as previously described (21, 22) . The purity was checked by PAGE, with and without SDS under reducing and nonreducing conditions and by complexing with rabbit anti-CSF-1 antibody (21, 22) . The purified CSF-1 was iodinated with carrier-free "I (Amersham Corp ., Arlington Heights, Ill .) with full retention of biological activity (16, 21) . The biological activity of the "'I-CSF-1 preparation was assessed either by radioimmunoassay with 131 1-CSF-I and double label counting (16, 21) or by immunoprecipitation with excess rabbit anti-CSF-t antiserum(21)on the basis of the closecorrelation between bioactivities and antibody-binding activities (l6, 21). Three different preparations of 'ZS I-CSF-I were used in the experiments described here . "'I-CSF-I preparations were stable when stored in HS-a-HEPES, alpha medium (KC Biological Inc., Kansas City, Mo.) containing 25 mM HEPES (Gibco Laboratories, Grand Island Biological Co ., Grand Island, N. Y.) in lieu of bicarbonate, pH 7.3, with 10% (vol/vol) horse serum (Flow Laboratories, Inc., Rockville, Md .), at -20°C (half-life of biologically active CSF-I = 50 d) . They were used no longer than 3 wk postiodination. Determinations of the specific radioactivities, as described elsewhere (2l), were made at the time of each experiment. The mean value was -106,000 cpm/ng of biologically active CSF-1 protein or 2,900 cpm/fmol, corresponding to an average of 1 atom of "'I per biologically active CSF-I molecule . Molarity conversions are based on an M, for the polypeptide moiety of CSF-1 of 28,000 (S . K. Das and E. R. Stanley, manuscript in preparation) (2l) and the specific activity of purified CSF-I (--1 .6 x 106 U/mg protein) (22) .
Preparation of Cells 8-to 12-wk-old female C3H/Anfmice (Cumberland Farms, Nashville, Tenn .) were used exclusively. Unless otherwise stated, the animals were killed by cervical dislocation and the cells suspended in HS-a-HEPES containing 5 U/ml Heparin (Upjohn Co., Agricultural Prods. MKT, Kalamazoo, Mich.) . When necessary, cell suspensions were cleared of large and small cellular debris as described elsewhere (15) . Viable cell counts were determined by Trypan blue exclusion and cell suspensions with viabilities of >95% were used in binding experiments. Unless otherwise stated, all operations were carried out at 4°C.
Bone marrow cells were obtained from femora, cleared of surrounding tissue and opened by scalpel at both ends . The narrow plug was ejected into medium by means of a syringe connected to the femur via a piece of silicon tubing. The cells were aspirated several times through the femur to ensure a single-cell suspension. The cell yield was -7 x 106 nucleated cells/femur. Spleen cells were obtained by forcing the tissue through a metal screen into the collecting medium. The suspension was aspirated several times with a Pasteur pipette to obtain a single-cell suspension . Approximately 10' cells were obtained from each spleen .
Blood mononuclear cells and granulocytes were obtained by the method of Boyum (2) . Mice were anaesthetized with ether and blood collected from the axillary artery and mixed with 0.3 M EDTA (50:1) to prevent coagulation. It was diluted (1 :4) with 0.15 M NaCl and layered over a mixture of 6.3% Ficoll (Pharmacia Fine Chemicals, Div. of Pharmacia Inc., Piscataway, N. J.) and 10% Hypaque (Winthrop Laboratories, New York, N. Y.) . The tube was centrifuged at 400 g for 30 min at 22°C. The interface layer of mononuclear cells was collected and washed three times with phosphate buffered saline (PBS) and resuspended in medium . The cell yield was 2-3 x 106 cells per mouse. The pellet of erythrocytes and granulocytes was resuspended in mouse serum containing 40 pM Dextran T500 (Pharmacia Fine Chemicals) . The cells were allowed to sediment (1 g, 4°C, l h) and the supernatant granulocytes were removed, washed twice with PBS (400 g, 4°C, 10 min), and resuspended in medium.
A single-cell suspension of thymus cells was obtained by teasing apart thymus tissue with a pair of #26 needles. The cells were washed twice with medium . Thymus gland yielded 5-8 x 10' cells .
Lymph node cells were collected from the inguinal, brachial, and mesenteric lymph nodes by gently teasing them apart with #26 needles until a single-cell suspension was obtained . The cells were washed twice; 2-4 x 10' cells were obtained per mouse.
Resident peritoneal cells were obtained by flushing the peritoneal cavity with 10 ml of cold medium as previously described (8) . Between 1-2 x 106 cells were recovered per cavity.
Pulmonary alveolar cells were obtained by cannulation of the trachea and lavage of the lungs three times with 0.5 mM EDTA in PBS (11) . Mice were killed beforehand by an intraperitoneal injection of 0.1 ml of Nembutal (Agricultural and Veterinary Products Division, Abbott Laboratories, North Chicago, Ill.). Between 2-3 x 10' cells were obtained from each mouse.
The macrophage cell line J-774.2 (6) has been shown to possess '25 1-CSF-I binding sites (5, 8) . This line was used to determine optimal binding conditions and as a reference cell population in most experiments. J-774.2 cells were maintained in a-medium with 10% horse serum in spinner flasks . They were harvested from cultures in log phase growth only (5-9 x 105 cells/ml) and their viability in all cases was >95%.
Cellular Binding of 125 
1-CSF-1
All operations were carried out at 0°C. Cells (usually 5 x 106 nucleated cells) in HS-a-HEPES were added to precooled plastic 35-mm tissue culture dishes (Lux Scientific Corp ., Newburg Park, Calif) and allowed to stand for 30 min. In the case of blood mononuclear, alveolar, and peritoneal cells, <5 x 106 nucleated cells per dish were used because of the limited cell yield per mouse. Stage 1 Lcell CSF-1 (22) in HS-a-HEPES was added to control dishes (final concentration 5 x 10-`°M) to saturate all CSF-1 binding sites before incubation with '2 'I-CSF-1 (2l). The remaining dishes received an equal volume of HS-a-HEPES . The contents of each dish were thoroughly mixed and allowed to incubate for 2 h. "I-CSF-I was then added to all dishes with mixing (final volume 1 ml) and the dishes incubated for a further 2 h. (For all cell populations studied, saturation was observed at the "'I-CSF-1 concentration routinely used for binding [5 x l0-'°M] .) The cells were then thoroughly resuspended and unbound ' 2'5 1-CSF-1 was removed by layering 0.8 ml of the suspension over 3 ml of filtered horse serum in a 12 x 75-mm polypropylene tube (Falcon #2053) and centrifuging (500 g, 15 min) . The supernate was removed by aspiration . The cell pellet was resuspended in 0.2 ml medium and quantitatively transferred to a new tube, 0.3 ml of medium was added and the tube was centrifuging (500 g, 10 min) immediately or after standing for 24 h. The supernate was discarded and the cell pellet on ice was counted for 'z.I in an LKB 1280 Ultrogamma counter (LKB Instruments, Inc., Rockville, Md .). Cells were resuspended in fetal calf serum and -I x 106 cells were smeared on precleaned glass slides. The cells were fixed in cold methanol for 15 min, washed three times in H2O, air-dried, and then processed for radioautography.
Radioautographs
Kodak NTB2 (Eastman Kodak Co., Rochester, N. Y.) was heated to 42°C and a thin layer was applied to each slide by dipping. They were enclosed in light-tight slideboxes, containing Drierite (W . A. Hammond Drierite Co ., Xenia, Ohio) as desiccant, and exposed at 4°C for 4, 7, or 14 d. Slides were developed at 22°C for 2 min in Kodak D-19 developer, dipped in 0.2 M acetic acid for 30 s and fixed for 3 min in Kodak Rapid Fixer. They were washed in running tap water for 15 min and rinsed in distilled water. The cells were stained in 0 .3% (wt/ vol) May-Griinwald in methanol for 15 min followed by 0.02% (wt/vol) Giemsa in 3 mM sodium phosphate buffer pH 6.8 for 30 min. The emulsion was destained in 20 mM acetic acid in ethanol, rinsed in buffer, and air-dried . Cells were examined with a Zeiss Standard WL Microscope (Carl Zeiss, Inc., N. Y.). The grain thresholdwas determined with the control cells that had been preincubated with unlabeled CSF-1. At least 1,000 sequential cells were examined in each preparation .
RESULTS
The binding conditions were determined using the macrophage cell line J-774.2 as the target cell population . Their ability to bind 125 I-CSF-I at 0°C has been previously demonstrated (8) .
Saturation of cellular binding was achieved, at concentrations of 125 1-CSF-1 >2 x 10 -' o M, within 2 h of incubation at 0°C
( Fig . 1 a) . There was a linear relationship between cpm bound and cell concentration in the range 1 x 105 to 1 x 10 6 cells/ml (Fig . 1 b) . Binding was essentially irreversible as 1251 counts remained cell bound when loaded cells were resuspended in CSF-1-free medium for 24 h at 0°C (data not shown) . Binding could be inhibited either by incubation in the presence of a 50-fold excess of "cold" unlabeled CSF-1 or by a 2 h preincubation with a saturating concentration of unlabeled CSF-1 (5 X 10-'o M) . This latter procedure was routinely adopted to minimize the use of unlabeled CSF-1 . Complete inhibition of 125 1 binding could not be achieved and the "net binding" refers to that which could be inhibited . Net binding is the difference between the two lines of Fig. 1 b.
Tissue cells were examined to see if the same binding conditions applied. Bone marrow and spleen cells were incubated with different concentrations of " 5 I-CSF-1 . Because of the lower incidence of binding cells in these suspensions, a higher cell concentration of 5 X 106 cells/ml was necessary . A linear relationship was found between cpm bound and cell concentration in the range 1 X 10 6 to 1 X 10'/ml (data not shown) . The labeled cells were morphologically classified into four types : blast cells ( Fig. 3 a) ; mononuclear cells with N/C > 1 ( Fig. 3 b) ; cells with indented nuclei (including large and small indentations) ( Fig. 3 c) ; and mononuclear cells with N/C :51 (Fig. 3 d) . Blast cells were distinguished by finely divided chromatin and sparse, often basophilic, cytoplasm. In the case of the peritoneal and pulmonary alveolar cells, a large proportion of the labeled cells that were classified as blast cells on the basis of their sparse peripheral cytoplasm, could have been multinucleated giant cells (macrophages), as their nuclear morphology was obscured by the large number of overlying grains (Fig. 3 e) . The greatest proportion of labeled cells in each tissue consisted of mononuclear cells with N/C > 1 . Labeled mononuclear cells with N/C :51 were found among lymph node, peritoneal and alveolar cells . Labeled cells with indented nuclei were found in all tissues except among alveolar cells. Table II illustrates the extent to which a cell of a given morphology possesses receptors for CSF-1 . In most cases both labeled and unlabeled cells of a particular morphology were found . However, in the case of blood mononuclear cells, all monocytes with the distinctive indented or horseshoe-shaped nuclei were found to be labeled. erythroid cells, and mature erythrocytes were always found to be unlabeled. The number of grains per cell is a function of the number of "'I-CSF-1 molecules bound. The distributions of grains per cell among binding cells were heterogeneous in most populations examined, including bone marrow (Fig. 4a) , alveolar (Fig. 4 c) and spleen and peritoneal cells (not shown) . However, as seen in Fig. 4b , blood mononuclear cells were relatively homogeneous in terms of the number of grains per cell (10-45 grains/cell, 3,000 binding sites/cell) . They consisted of mononuclear cells with N/C > 1 (68%) and cells with accentuated nuclear identations (32%) ( Table II) , both of which were characterized as monocytes (see Discussion). Analysis of all three tissues represented in Fig . 4 failed to reveal any other striking correlation between cellular morphology and grain counts per cell. However, the binding cells in the pulmonary alveolar (Table I) in the tissues examined are in general agreement with the previously reported frequencies of mononuclear phagocytic cells in these tissues (bone marrow [27] , blood monocytes from Ficoll-Hypaque sedimentation [4, 10] , splenic monocytes or macrophages [ 12] , and peritoneal macrophages [23, 26] ) . An exception to this Since the alveolar cells were labeled with a ' 25 1-CSF-1 preparation of lower specific radioactivity (2,400 cpm/fmol) than the preparation used for the bone marrow and blood mononuclear cells (3,700 cpm/ fmol), the data in histogram c were normalized . The average grain count per labeled bone marrow cell was divided by the average number of receptors per labeled bone marrow cell (Table I ) and the resulting ratio multiplied by the average number of receptors per labeled alveolar cell (Table I ) to obtain a normalized average grain count per labeled alveolar cell (-1 .5 times the actual average grain count) . The distribution of grain counts per labeled alveolar cell was then moved to the right by an amount equal to the difference between the normalized and actual average grain count per labeled alveolar cell . 85 2 THE JOURNAL OF CELL BIOLOGY " VOLUME 91, 1981 observation was that the frequency of alveolar cells binding CSF-1 was much lower than the reported frequencies of alveolar macrophages in such preparations (1, 10) . Indeed, many alveolar cells, which by classical morphological criteria are macrophages (N/C <_1, Fig. 3d ), did not bind CSF-1 . (d) In all tissues examined the frequency of cells which respond to CSF-1 by forming colonies of macrophages (18) was equal to or less than the frequency of binding cells.' Taken together, the above evidence strongly suggests that the CSF-1 receptor is restricted to undifferentiated and differentiated members of the mononuclear phagocytic cell lineage. The reason why some macrophages, i.e ., the alveolar subset mentioned above, do not bind CSF-1 is unclear.
Grain counts in radioautographs indicated that the number of CSF-1 binding sites per cell varied among binding cells (Fig .  4) . With the exception of the relatively homogeneous distribution for blood mononuclear cells, all tissues examined exhibited heterogeneous distributions of grain counts per cell . CSF-1 binding alveolar cells, of larger average size than binding cells from other tissues, also possessed a higher average number of receptors than cells from other tissues (Table I ) . In agreement with this, the frequency distribution of grain counts associated with these cells was shifted towards higher grain counts per cell compared with the distributions of CSF-1 binding cells in bone marrow and blood (Fig. 4) . The observed heterogeneity among CSF-1 binding cells in tissues other than blood could be explained in a variety of ways, e.g., microenvironmental variations in CSF-1 concentration, cell cycle state, or state of differentiation .
An excellent correlation exists between the reported tissue distribution of monocytes and the tissue distribution of cells with grain counts of between 10 and 45 grains . Virtually all of the mononuclear phagocytic cells in the peripheral blood ' In this regard, it would appear that the presence of the receptor is necessary but is not sufficient for the CSF-1 proliferative response . However, it has recently become clear that although not all CSF-1 receptor bearing cells have the capacity to proliferate, those that do not may respond to CSF-1 in other ways (9, 10 mononuclear cell population are monocytes and 70-80% of those in bone marrow are monocytes (7, 24) . CSF-1 binding blood mononuclear cells are tightly distributed (98% of binding cells have between 10 and 45 grains per cell). The major peak (71%) of the more heterogeneously distributed binding cells in bone marrow fall within this "monocyte" range. Thus it appears that the major binding cell class in blood and bone marrow is the monocyte, of which approximately two-thirds are mononuclear cells with N/C >1 and one-third cells with deeply indented nuclei (Table II) Table II ). It is significant that <5% of the CSF-1 binding cells in this population have <45 grains per cell ; i.e., the alveolar cell distribution (Fig . 4 c) lacks the "monocyte" peak .
The distribution, frequencies and morphologies of CSF-1 binding cells in murine tissues suggest that the CSF-1 receptor is a specific marker of mononuclear phagocytic cells and their precursors . The results demonstrate that binding by specific growth factors may be used as a means of identifying both mature and immature cells of a differentiating cell lineage.
